Association of Baseline Serum Soluble Tumour Necrosis Factor Receptor Levels with the Response of Rheumatoid Arthritis to Janus Kinase Inhibitor Therapy

<div>Comparison of various cytokines in the CR and non-CR groups. (a) interleukin-6 (IL-6), (b) soluble IL-6 receptor (IL-6R), (c) soluble gp130, (d) soluble tissue necrosis factor receptor-I (TNFR-I), (e) soluble TNFR-II and (f) soluble TNFR II/I ratio.</div>

International Journal of Rheumatology

fig1

Figure 1

Figure 1: Association of Baseline Serum Soluble Tumour Necrosis Factor Receptor Levels with the Response of Rheumatoid Arthritis to Janus Kinase Inhibitor Therapy 

Figure 1 | Association of Baseline Serum Soluble Tumour Necrosis Factor Receptor Levels with the Response of Rheumatoid Arthritis to Janus Kinase Inhibitor Therapy 